I wish I knew which drugs using our WI's were in clinical testing. However here is a list of AstraZeneca biologics nearing filing that might be using our WI's for testing. Also AS used a plural form of Clinical Trials during the Imperium announcement so ...
AZ/MedImmune Biologics Pipeline (as of Dec 2014) (Just the one's with expected US filings ... 15 more with no dates)
MEDI4736 | anti-PD-1 mAb | NSCLC | 1H16
Moxetumomab pasudotox | anti-CD22 immunotoxin | Hairy cell Leukemia | 2018
Tremelimumab | anti-CTLA-4 mAb | Mesothelioma | 1H16
Benralizumab | anti-IL-5R mAb | Severe asthma | 2H16
Brodalumab | anti-IL-17R mAb | Psoriasis/psoriatic arthritis | 2015
Tralokinumab | anti-IL-13R mAb | Severe asthma | 2018
UNS Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
